AIHTA - Publications - Search - Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of muscle-invasive urothelial carcinoma (MIUC)

Wolf, S. (2022): Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of muscle-invasive urothelial carcinoma (MIUC). Oncology Fact Sheet Nr. 81.

[thumbnail of Oncology Fact Sheet Nr.81.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
113kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WJ Urogenital system > WJ 400-600 Ureter. Bladder. Urethra
Language:English
Series Name:Oncology Fact Sheet Nr. 81
Deposited on:28 Mar 2022 12:38
Last Modified:16 May 2022 09:34

Repository Staff Only: item control page